About InvestorForum
Showcasing the Leading Growth Companies in Life Sciences
October 19-20, 2005
Palace Hotel, San Francisco
ORGANIZER: Biotechnology Industry Organization
HOST: Bank of America and Lehman Brothers
CO-HOSTS: CIBC World Markets, Jefferies and RBC Capital Markets
SUPPORTING PARTNERS: BayBio, BIOCOM and BIOTECanada
MISSION: A national investor forum to explore investment trends and opportunities in life sciences, with a focus on public and venture-stage growth companies as well as those poised to join the growth “watch list” in 2006
PROGRAM: The BIO InvestorForum delivered a rich program that featured corporate presentations and panel debates on the sweet spots and growth challenges facing the industry:
- more than 190 public and venture-stage companies presented
- over 14 expert-led workshops on the latest market and investment opportunities with emphasis on drug and technology development
- one-on-one investor meetings
- breakout sessions between presenting company executives and investors
- premier opportunity to network with industry executives and investors focused exclusively on life sciences
TARGET AUDIENCE: Public and private equity investors, research analysts, investment bankers and senior-level industry executives focused on investment trends and business development opportunities in life sciences
Companies Attended To:
- Present company story to an audience of target investors
- Meet one-on-one with new and current investors, analysts, investment bankers and other potential corporate partners
- Hear candid panel discussions and keynotes by veteran investment and company executives
- Network with peers, investors and potential partners attending the conference
- Get the pulse on the current and proposed investment trends in life sciences
Investors Attended To:
- Hear from and meet one-on-one with management from the top life sciences growth companies and those poised to join the growth “watch list” next year
- Evaluate fresh investment opportunities including compatible, complementary and competitive companies
- Attend candid panel discussions with leading clinical experts and company experts on the latest therapies and technologies in development
- Get a ‘big picture’ overview of the industry and the issues affecting investments now and for 2006